sEAPort: Expanded Access Program

A Multicenter Expanded Access Program Protocol for Melflufen (Melphalan Flufenamide) in Combination with Dexamethasone in Patients with Triple-Class Refractory Multiple Myeloma. Melflufen is an investigational...